Acute Myocardial Infarction: Diagnosis and Management

Dear Colleagues,

Acute myocardial infarction (AMI) is one of the leading causes of morbidity and mortality in the developed world with a prevalence of approximately three million people worldwide despite substantial improvements in prognosis over the past decade. This improvement is a result of several major trends, including risk stratification, the use of early invasive strategy through percutaneous coronary intervention (PCI), the use of mechanical support devices in cardiogenic shock complicating AMI, better antiplatelet agents and anticoagulants, and better knowledge about the importance of secondary prevention strategies (such as statins). AMI can be divided into two categories, i.e., non-ST segment elevation MI (NSTEMI) and ST segment elevation MI (STEMI), although new categories (such as acute coronary occlusion MI (OMI) vs. non-occlusion MI (NOMI)) have also been suggested.

This Special Issue aims to provide a comprehensive picture on this dynamic research area by gathering contributions that cover all aspects related to the topic, including the diagnosis (e.g., ECG, troponin, novel biomarkers, artificial intelligence, nationwide surveys, etc.) and management of AMI; cardiogenic shock complicating AMI (e.g., primary PCI, mechanical support devices [e.g., primary PCI, mechanical support devices (such as Impella, extracorporeal membrane oxygenation, intra-aortic balloon pump), transcatheter aortic valve implantation and Mitral clips in the setting of AMI, anti-platelet agents and anticoagulants, PCSK-9 inhibitor statins]; and short- and long-term prognosis of AMI (e.g., trends, nationwide surveys, and future perspective).  

Contributions may be related to any aspect of AMI and should expand on the knowledge surrounding such topics.

Dr. Elad Asher
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.